Bio Fil AB Medicated Collagen Particles represent an advanced wound care solution combining natural collagen healing properties with potent antibiotic agents. These sterile particles contain mupirocin USP 2% w/w and metronidazole IP 1% w/w, creating an optimal healing environment while effectively combating bacterial infections. The product is specifically engineered to address challenging wound conditions, including those resistant to conventional treatments. Its unique formulation ensures sustained medication release directly at the infection site, providing continuous therapeutic action without systemic side effects. This targeted approach makes it essential for medical professionals managing complex wound scenarios where infection control is crucial for successful patient outcomes and reduced recovery times.

This medicated collagen product serves multiple healthcare sectors including hospital wound care departments, specialized burn units, diabetic foot clinics, and long-term care facilities. It proves particularly valuable in surgical settings where post-operative infections threaten patient recovery. The veterinary field also utilizes these collagen particles for complex animal wounds, demonstrating cross-medical versatility. Dermatology clinics employ it for chronic skin ulcers, while orthopedic specialists use it for cases involving exposed bone or joint infections. The broad-spectrum antibacterial action covers both gram-positive and gram-negative organisms, addressing common pathogens found in wound infections across different medical specialties and patient populations.

For healthcare suppliers and medical distributors, Bio Fil AB Collagen Particles offer exceptional reliability and consistent performance that builds professional trust. The product undergoes rigorous quality control ensuring batch-to-batch consistency and sterility compliance. The dual antibiotic formulation provides competitive advantage in markets where single-antibiotic products fail against complex polymicrobial infections. This reliability translates into repeat business and strong customer loyalty, as medical facilities can standardize wound care protocols around a product delivering predictable positive outcomes even in challenging clinical situations, ultimately supporting better patient care and operational efficiency.

Key Features:
- Contains mupirocin USP 2% w/w and metronidazole IP 1% w/w
- Sterile collagen particles for direct wound bed application
- Sustained release formulation for prolonged antibiotic action
- Broad-spectrum coverage against gram-positive and anaerobic bacteria
- Consistent quality with rigorous manufacturing standards

Benefits:
- Effective infection control for chronic and complex wounds
- Targeted antibiotic delivery minimizes systemic side effects
- Supports natural healing process through collagen matrix
- Reduces treatment time with sustained medication release
- Trusted performance for standardized wound care protocols